Change Theme
CNBC TV18
Mon, Sep 16, 2024
Strides Pharma receives approval to expand antidepressant line in the US
Shares of Strides Pharma Science Ltd ended at ₹1,391.55, up by ₹38.05, or 2.81%, on the BSE.